Katharina Willuweit Selected Research

Liver Cirrhosis (Hepatic Cirrhosis)

11/2023	Tiza-Titre increase and enhanced immunity through an adjuvanted, recombinant herpes zoster subunit vaccine in patients with liver cirrhosis and post-liver transplantation: a study protocol for a prospective cohort study.
4/2022	FIB-4 and APRI as Predictive Factors for Short- and Long-Term Survival in Patients with Transjugular Intrahepatic Portosystemic Stent Shunts.
4/2022	Safe for Mother, Baby, and Graft? Pregnancy After Liver Transplant: A Single-Center Experience.
2/2022	Patients with Liver Cirrhosis Show High Immunogenicity upon COVID-19 Vaccination but Develop Premature Deterioration of Antibody Titers.
1/2021	Enzymatic liver function measured by LiMAx is superior to current standard methods in predicting transplant-free survival after TIPS implantation.
1/2020	Standard coagulation tests are superior to thromboelastometry in predicting outcome of patients with liver cirrhosis.
1/2019	Liver Maximum Capacity: A Novel Test to Accurately Diagnose Different Stages of Liver Fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katharina Willuweit Research Topics

Disease

7	Liver Cirrhosis (Hepatic Cirrhosis) 11/2023 - 01/2019
6	Fibrosis (Cirrhosis) 10/2023 - 03/2017
4	End Stage Liver Disease 10/2023 - 05/2019
4	Infections 06/2021 - 01/2017
2	Liver Diseases (Liver Disease) 10/2023 - 01/2019
2	Sepsis (Septicemia) 05/2023 - 01/2019
2	Sclerosing Cholangitis 05/2023 - 06/2021
2	Thrombosis (Thrombus) 05/2023 - 01/2019
2	Hepatocellular Carcinoma (Hepatoma) 04/2023 - 12/2021
2	Chronic Hepatitis C 01/2019 - 01/2017
2	Virus Diseases (Viral Diseases) 01/2019 - 01/2017
1	Herpes Zoster 11/2023
1	Acute-On-Chronic Liver Failure 10/2023
1	Chronic Hepatitis D 04/2023
1	Hepatitis 04/2023
1	Hepatitis D 04/2023
1	Portal Hypertension 04/2022
1	Ascites 04/2022
1	Cytomegalovirus Infections (Inclusion Disease) 06/2021
1	Diabetes Mellitus 07/2019
1	Shock 01/2019
1	Vasoplegia 01/2019
1	Inflammation (Inflammations) 01/2019
1	Reinfection 03/2017

Drug/Important Bio-Agent (IBA)

2	Alanine Transaminase (SGPT)IBA 04/2023 - 01/2019
2	InterferonsIBA 04/2023 - 03/2017
2	AntibodiesIBA 02/2022 - 08/2020
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2019
2	SofosbuvirIBA 03/2017 - 01/2017
1	Subunit VaccinesIBA 11/2023
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2023
1	IronIBA 04/2023
1	bulevirtideIBA 04/2023
1	Messenger RNA (mRNA)IBA 02/2022
1	BNT162 VaccineIBA 02/2022
1	VaccinesIBA 02/2022
1	Immunoglobulin G (IgG)IBA 02/2022
1	Nucleic AcidsIBA 06/2021
1	Everolimus FDA Link 07/2019
1	grazoprevirIBA 01/2019
1	Immunoglobulin M (IgM)IBA 01/2019
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2019
1	Antiviral Agents (Antivirals)IBA 01/2019
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2019
1	MTOR InhibitorsIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	ProcalcitoninIBA 01/2019
1	elbasvirIBA 01/2019
1	Hemostatics (Antihemorrhagics)IBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	Ribavirin (Virazole)FDA LinkGeneric 03/2017
1	ledipasvirIBA 01/2017

Therapy/Procedure

12	Liver Transplantation 11/2023 - 03/2017
3	Transplantation 05/2023 - 01/2017
3	Therapeutics 04/2022 - 01/2017
2	Surgical Portasystemic Shunt (Portosystemic Shunt) 04/2022 - 01/2021
2	Transjugular Intrahepatic Portasystemic Shunt 04/2022 - 01/2021
1	Contraindications 01/2017